GAME ON: Market price of sports media platform has zoomed 78% in one month
In the past six months, the stock price of Brightcom Group has zoomed 1006 per cent, as compared to a 20.5 per cent rise in the S&P BSE Sensex
The stock now trades at record high levels, backed by strong Q2FY22 revenue growth, the company reports 78 per cent year on year (YoY) jump in standalone revenue for the July-September quarter (Q2FY22
In the past one month, the market price of IRCTC has soared 50 per cent, as compared to a 2.5 per cent rise in the S&P BSE Sensex
The Nifty Media index jumped 13.57 per cent on Wednesday, as compared to a 0.087 per cent fall in the Nifty50
On September 14, 2021, Rare Enterprises had bought 5 million equity shares of ZEEL at Rs 220.44 per share
As part of the transaction, Punit Goenka will continue to be the managing director and chief executive officer (CEO) of the merged entity
Despite today's sharpest rally, the stock has under-performed the market gaining 28 per cent, as against a 50 per cent surge in the S&P BSE Sensex.
Analysts positive on institutional shareholders Invesco, OFI Global's call for removal of Goenka as director
Rallies 29% in 7 days; analysts say firm well placed to execute order book
The stock has corrected about 9 per cent from its record level of Rs 644 touched on August 16
With Rs 2.51 trillion market cap at 12:18 pm, Avenue Supermarts stood at 15th position in the overall m-cap ranking
In the past month, TCS has outperformed the market by surging 15 per cent, as compared to a 6 per cent rise in the S&P BSE Sensex
The company would be setting up an Asset Management Company and the Trustee Company to sponsor the MF
HCL Tech became the fourth Indian information technology (IT) firm to achieve the milestone after Tata Consultancy Services (TCS), Infosys and Wipro
Airtel has received Rs 1,004.8 crore (net of tax) from Jio for the proposed transfer.
A quick calendar year-to-date price check on the stocks from the categories put under 'Add-on Price Band Framework' by the BSE reveals a total of 210 stocks have seen their price more than double
The company missed Street expectations due to lower net interest income (NII)
In last three weeks, stock has surged 27% after the company reported a strong operational performance in Q1
The pharmaceutical company reported a disappointing April-June quarter (Q1FY22) performance on the margins front